FDA
Biotech

FDA gene therapy regulator steps down from leadership role

Acting CBER Director Karim Mikhail will oversee the Office of Therapeutic Products until a new permanent leader is found.
Darren Incorvaia Jun 30, 2026 10:36am
iStock-654068644png

Abivax stock rebounds on colitis prospect safety data

Jun 30, 2026 10:27am
A photo finish at a horse race with both horses crossing the finish line

China approved the first solid tumor CAR-T. Will the US follow?

Jun 30, 2026 10:00am
Goal disorientation and lack of vision

Vistagen fails another phase 3 anxiety trial, spies path forward

Jun 30, 2026 9:48am
A ballpoint pen rests on top of a stack of documents ready for signing

Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE

Jun 30, 2026 8:00am
Worker bees in hive seen through honeycomb

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am
More News

Praxis faces FDA delay, analysts point finger at agency layoffs

Jun 30, 2026 4:13am
Fierce Pharma

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am

BioCryst ends internal programs in pivot to partnerships

Jun 29, 2026 10:30am

Evommune’s phase 2b flops, ending challenge to Novartis in hives

Jun 29, 2026 10:00am